why choose us

First received: December 22, 2023

Clinical Trial: Drug Interaction Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Drug Interaction

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Sequential Drug Interaction Study to Evaluate the Effect of CYP3A4 and P-glycoprotein Inhibition by Itraconazole or Induction by Rifampicin on the Pharmacokinetics of Ecopipam and Its Metab

Brief Summary: This is a single center, 2-Part, Phase 1, open-label, fixed-sequence, drug-drug interaction study designed to compare the PK of ecopipam when administered alone and in combination with itraconazole (Part 1) or rifampicin (Part 2) in healthy subjects.

Read more